BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24048798)

  • 1. Additive effect on survival of Raf kinase inhibitor protein and signal transducer and activator of transcription 3 in high-grade glioma.
    Maresch J; Birner P; Zakharinov M; Toumangelova-Uzeir K; Natchev S; Guentchev M
    Cancer; 2011 Jun; 117(11):2499-504. PubMed ID: 24048798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome.
    Chatterjee D; Sabo E; Tavares R; Resnick MB
    Clin Cancer Res; 2008 May; 14(10):2994-3001. PubMed ID: 18483365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
    Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
    J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.
    Cross-Knorr S; Lu S; Perez K; Guevara S; Brilliant K; Pisano C; Quesenberry PJ; Resnick MB; Chatterjee D
    BMC Cancer; 2013 Oct; 13():463. PubMed ID: 24098947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raf kinase inhibitor protein (RKIP) in cancer.
    Escara-Wilke J; Yeung K; Keller ET
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):615-20. PubMed ID: 22684368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.
    Yousuf S; Duan M; Moen EL; Cross-Knorr S; Brilliant K; Bonavida B; LaValle T; Yeung KC; Al-Mulla F; Chin E; Chatterjee D
    PLoS One; 2014; 9(3):e92478. PubMed ID: 24658061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of low- to high-grade astrocytomas reveals an alteration of the expression level of raf kinase inhibitor protein and nucleophosmin.
    Gimenez M; Souza VC; Izumi C; Barbieri MR; Chammas R; Oba-Shinjo SM; Uno M; Marie SK; Rosa JC
    Proteomics; 2010 Aug; 10(15):2812-21. PubMed ID: 20533335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of Raf-1 kinase inhibitory protein in renal cell carcinoma: a significant prognostic marker.
    Moon A; Park JY; Sung JY; Park YK; Kim YW
    Pathology; 2012 Oct; 44(6):534-9. PubMed ID: 22935977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Raf-1 kinase inhibitor protein expression predicts less favorable outcomes in patients with hepatic colorectal metastasis.
    Kim HS; Park SJ; Lee KY; Park YK; Kim YW
    Oncol Rep; 2012 Jul; 28(1):161-71. PubMed ID: 22562283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
    Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
    Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of Raf kinase inhibitor protein and its significance in invasion and metastasis of hepatocellular carcinoma].
    Wu XH; Wang SX; Yang YJ; Li JK; Xu Z; Tang RF
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):358-62. PubMed ID: 21875465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
    Haura EB; Zheng Z; Song L; Cantor A; Bepler G
    Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas.
    Martinho O; Granja S; Jaraquemada T; Caeiro C; Miranda-Gonçalves V; Honavar M; Costa P; Damasceno M; Rosner MR; Lopes JM; Reis RM
    PLoS One; 2012; 7(1):e30769. PubMed ID: 22292035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of YAP1 and pSTAT3-S727 and their prognostic value in glioma.
    Sang W; Xue J; Su LP; Gulinar A; Wang Q; Zhai YY; Hu YR; Gao HX; Li X; Li QX; Zhang W
    J Clin Pathol; 2021 Aug; 74(8):513-521. PubMed ID: 33020176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.
    Fu Z; Kitagawa Y; Shen R; Shah R; Mehra R; Rhodes D; Keller PJ; Mizokami A; Dunn R; Chinnaiyan AM; Yao Z; Keller ET
    Prostate; 2006 Feb; 66(3):248-56. PubMed ID: 16175585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis.
    Hagan S; Al-Mulla F; Mallon E; Oien K; Ferrier R; Gusterson B; García JJ; Kolch W
    Clin Cancer Res; 2005 Oct; 11(20):7392-7. PubMed ID: 16243812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma.
    Kim HS; Won KY; Kim GY; Kim SC; Park YK; Kim YW
    Pathol Res Pract; 2012 May; 208(5):292-9. PubMed ID: 22464151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
    Das G; Shiras A; Shanmuganandam K; Shastry P
    Mol Carcinog; 2011 Jun; 50(6):412-23. PubMed ID: 21557327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B; Chang CM; Yuan M; McKenna WG; Shu HK
    Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.